Furthermore, we also examined the potential association between WWOX gene polymorphisms and the clinicopathological markers of HCC, including α-fetoprotein, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and the AST/ALT ratio. This evidence concerns the gene WWOX and hepatocellular carcinoma.